(-)-matairesinol decreases activity ISO Acp5 (Mus musculus) 6480464 matairesinol results in decreased activity of ACP5 protein CTD PMID:24444335 (20S)-ginsenoside Rg3 multiple interactions EXP 6480464 ginsenoside Rg3 inhibits the reaction [Dexamethasone results in increased activity of ACP5 protein] CTD PMID:27387537 1,2,4-trimethylbenzene decreases expression EXP 6480464 pseudocumene results in decreased expression of ACP5 protein CTD PMID:17337753 1,4-dichlorobenzene increases expression ISO Acp5 (Mus musculus) 6480464 4-dichlorobenzene results in increased expression of ACP5 mRNA CTD PMID:26975756 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases expression ISO Acp5 (Mus musculus) 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:30529163 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of ACP5 mRNA CTD PMID:25380136 17alpha-ethynylestradiol increases expression ISO Acp5 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of ACP5 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO Acp5 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACP5 mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression ISO Acp5 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of ACP5 mRNA CTD PMID:17555576 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of ACP5 protein CTD PMID:15917159 17beta-estradiol multiple interactions ISO ACP5 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of ACP5 mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Acp5 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACP5 mRNA and Tetrachlorodibenzodioxin results in increased expression of and results in increased secretion of ACP5 protein CTD PMID:17942748 and PMID:29673856 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ACP5 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ACP5 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ACP5 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Acp5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of ACP5 mRNA CTD PMID:17035482 and PMID:21041162 2-aminopurine multiple interactions ISO Acp5 (Mus musculus) 6480464 2-Aminopurine inhibits the reaction [[TNF protein co-treated with TNFSF11 protein] results in increased expression of ACP5 protein] CTD PMID:25739386 2-hydroxypropanoic acid decreases expression ISO ACP5 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of ACP5 mRNA CTD PMID:30851411 3,4-methylenedioxymethamphetamine increases methylation ISO Acp5 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased methylation of ACP5 promoter CTD PMID:26251327 3,4-methylenedioxymethamphetamine increases expression ISO Acp5 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of ACP5 mRNA CTD PMID:26251327 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of ACP5 mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol decreases methylation ISO Acp5 (Mus musculus) 6480464 bisphenol S results in decreased methylation of ACP5 promoter CTD PMID:33297965 4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamide multiple interactions ISO Acp5 (Mus musculus) 6480464 Cisapride inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] CTD PMID:31150804 4-hydroxyphenyl retinamide multiple interactions ISO Acp5 (Mus musculus) 6480464 Fenretinide inhibits the reaction [TNF protein results in increased expression of ACP5 protein] CTD PMID:16230421 4-hydroxyphenyl retinamide decreases expression ISO Acp5 (Mus musculus) 6480464 Fenretinide results in decreased expression of ACP5 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO ACP5 (Homo sapiens) 6480464 Decitabine affects the expression of ACP5 mRNA CTD PMID:17145863 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of ACP5 mRNA CTD PMID:30047161 acetamide increases expression EXP 6480464 acetamide results in increased expression of ACP5 mRNA CTD PMID:31881176 aflatoxin B1 increases expression ISO ACP5 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of ACP5 mRNA CTD PMID:21641981 aflatoxin B1 decreases expression ISO ACP5 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of ACP5 mRNA CTD PMID:27153756 alendronic acid multiple interactions EXP 6480464 Alendronate inhibits the reaction [Dexamethasone results in increased activity of ACP5 protein] and Alendronate inhibits the reaction [modafinil results in increased expression of ACP5 mRNA] CTD PMID:27387537 and PMID:29649498 all-trans-retinoic acid increases expression ISO Acp5 (Mus musculus) 6480464 Tretinoin results in increased expression of ACP5 mRNA CTD PMID:16604517 all-trans-retinoic acid multiple interactions ISO Acp5 (Mus musculus) 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ACP5 mRNA CTD PMID:36189433 aluminium oxide decreases expression ISO ACP5 (Homo sapiens) 6480464 Aluminum Oxide results in decreased expression of ACP5 mRNA CTD PMID:15585240 amitrole increases expression EXP 6480464 Amitrole results in increased expression of ACP5 mRNA CTD PMID:30047161 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO Acp5 (Mus musculus) 6480464 crocin promotes the reaction [pyrazolanthrone inhibits the reaction [TNFSF11 protein results in increased activity of ACP5 protein]] and pyrazolanthrone inhibits the reaction [TNFSF11 protein results in increased activity of ACP5 protein] CTD PMID:30580027 aristolochic acid A increases expression ISO ACP5 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of ACP5 mRNA CTD PMID:33212167 azadirachtin A multiple interactions ISO Acp5 (Mus musculus) 6480464 azadirachtin inhibits the reaction [Estrogens deficiency results in increased expression of ACP5 mRNA] CTD PMID:31225646 azadirachtin A decreases expression ISO Acp5 (Mus musculus) 6480464 azadirachtin results in decreased expression of ACP5 mRNA CTD PMID:31225646 beclomethasone decreases activity ISO ACP5 (Homo sapiens) 6480464 Beclomethasone results in decreased activity of ACP5 protein CTD PMID:8429434 belinostat decreases expression ISO ACP5 (Homo sapiens) 6480464 belinostat results in decreased expression of ACP5 mRNA CTD PMID:27188386 benzamide multiple interactions ISO Acp5 (Mus musculus) 6480464 benzamide analog inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of ACP5 mRNA] CTD PMID:29935282 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of ACP5 mRNA CTD PMID:21839799 benzo[a]pyrene increases activity ISO Acp5 (Mus musculus) 6480464 Benzo(a)pyrene results in increased activity of ACP5 protein CTD PMID:35777681 benzo[a]pyrene affects methylation ISO ACP5 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of ACP5 5' UTR and Benzo(a)pyrene affects the methylation of ACP5 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO ACP5 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of ACP5 mRNA CTD PMID:20064835 and PMID:22316170 Bergenin multiple interactions ISO Acp5 (Mus musculus) 6480464 bergenin inhibits the reaction [[TNFSF11 protein co-treated with Pyruvaldehyde] results in decreased activity of ACP5 protein] CTD PMID:31369791 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ACP5 mRNA CTD PMID:25181051 bisphenol A increases expression ISO Acp5 (Mus musculus) 6480464 bisphenol A results in increased expression of ACP5 mRNA CTD PMID:32156529 more ... bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ACP5 mRNA CTD PMID:32145629 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of ACP5 gene CTD PMID:28505145 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of ACP5 protein alternative form CTD PMID:23954550 cadmium atom multiple interactions ISO Acp5 (Mus musculus) 6480464 1 more ... CTD PMID:31793751 more ... cadmium dichloride multiple interactions ISO Acp5 (Mus musculus) 6480464 [Cadmium Chloride co-treated with TNFSF11] results in increased activity of ACP5 protein more ... CTD PMID:21723911 more ... cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of ACP5 mRNA CTD PMID:25993096 calcitriol decreases expression ISO ACP5 (Homo sapiens) 6480464 Calcitriol results in decreased expression of ACP5 protein CTD PMID:21985997 carbon nanotube increases expression ISO Acp5 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube decreases expression ISO Acp5 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of ACP5 mRNA CTD PMID:23125180 chlorpromazine multiple interactions ISO Acp5 (Mus musculus) 6480464 Chlorpromazine inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] CTD PMID:21869564 chlorpyrifos increases expression ISO Acp5 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of ACP5 mRNA CTD PMID:32715474 chromium atom decreases activity EXP 6480464 Chromium results in decreased activity of ACP5 protein CTD PMID:16866188 cisapride multiple interactions ISO Acp5 (Mus musculus) 6480464 Cisapride inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] CTD PMID:31150804 cisplatin increases expression ISO ACP5 (Homo sapiens) 6480464 Cisplatin results in increased expression of ACP5 mRNA CTD PMID:27594783 cisplatin multiple interactions ISO ACP5 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of ACP5 mRNA CTD PMID:27392435 clofibrate decreases expression ISO Acp5 (Mus musculus) 6480464 Clofibrate results in decreased expression of ACP5 mRNA CTD PMID:17585979 copper(II) sulfate decreases expression ISO ACP5 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of ACP5 mRNA CTD PMID:19549813 crocin-1 multiple interactions ISO Acp5 (Mus musculus) 6480464 crocin promotes the reaction [pyrazolanthrone inhibits the reaction [TNFSF11 protein results in increased activity of ACP5 protein]] CTD PMID:30580027 cyclosporin A multiple interactions ISO Acp5 (Mus musculus) 6480464 Cyclosporine inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein] CTD PMID:15207740 cyclosporin A decreases expression ISO ACP5 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of ACP5 mRNA CTD PMID:27989131 Cyclosporin H multiple interactions ISO Acp5 (Mus musculus) 6480464 cyclosporin H inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein] CTD PMID:15207740 desferrioxamine B multiple interactions ISO Acp5 (Mus musculus) 6480464 Deferoxamine inhibits the reaction [TF protein results in increased activity of ACP5 protein] and TF protein inhibits the reaction [Deferoxamine results in decreased activity of ACP5 protein] CTD PMID:31238089 desferrioxamine B decreases activity ISO Acp5 (Mus musculus) 6480464 Deferoxamine results in decreased activity of ACP5 protein CTD PMID:31238089 dexamethasone multiple interactions ISO ACP5 (Homo sapiens) 6480464 [Thalidomide co-treated with Dexamethasone] results in decreased expression of ACP5 protein CTD PMID:16079895 dexamethasone increases activity EXP 6480464 Dexamethasone results in increased activity of ACP5 protein CTD PMID:27387537 and PMID:28363435 dexamethasone multiple interactions EXP 6480464 Alendronate inhibits the reaction [Dexamethasone results in increased activity of ACP5 protein] more ... CTD PMID:27387537 and PMID:28363435 dexamethasone increases expression ISO Acp5 (Mus musculus) 6480464 Dexamethasone results in increased expression of ACP5 mRNA CTD PMID:21041162 diethylstilbestrol increases expression ISO Acp5 (Mus musculus) 6480464 Diethylstilbestrol results in increased expression of ACP5 mRNA CTD PMID:21041162 diosgenin multiple interactions ISO Acp5 (Mus musculus) 6480464 Diosgenin inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein] CTD PMID:16331273 diosmetin multiple interactions ISO Acp5 (Mus musculus) 6480464 diosmetin inhibits the reaction [RANK Ligand affects the expression of ACP5 mRNA] CTD PMID:36563736 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ACP5 mRNA CTD PMID:33729688 dithionite(2-) decreases activity EXP 6480464 Dithionite results in decreased activity of ACP5 protein CTD PMID:6886379 dithionite(2-) multiple interactions EXP 6480464 ferrous chloride inhibits the reaction [Dithionite results in decreased activity of ACP5 protein] CTD PMID:6886379 diuron increases expression EXP 6480464 Diuron results in increased expression of ACP5 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO ACP5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO ACP5 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of ACP5 mRNA CTD PMID:29803840 ellagic acid multiple interactions ISO Acp5 (Mus musculus) 6480464 Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] and Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein] CTD PMID:32971123 entinostat increases expression ISO ACP5 (Homo sapiens) 6480464 entinostat results in increased expression of ACP5 mRNA CTD PMID:26272509 entinostat multiple interactions ISO ACP5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACP5 mRNA CTD PMID:27188386 ethanol multiple interactions ISO Acp5 (Mus musculus) 6480464 Vitamin D inhibits the reaction [Ethanol results in increased expression of ACP5 mRNA] CTD PMID:22892342 ethanol increases expression ISO Acp5 (Mus musculus) 6480464 Ethanol results in increased expression of ACP5 mRNA CTD PMID:22892342 ferric ammonium citrate increases expression EXP 6480464 ferric ammonium citrate results in increased expression of ACP5 protein CTD PMID:36087815 ferric ammonium citrate multiple interactions EXP 6480464 Silybin inhibits the reaction [ferric ammonium citrate results in increased expression of ACP5 protein] CTD PMID:36087815 fluoxetine multiple interactions ISO Acp5 (Mus musculus) 6480464 Fluoxetine inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] CTD PMID:15312242 formononetin multiple interactions ISO Acp5 (Mus musculus) 6480464 formononetin inhibits the reaction [Streptozocin results in increased activity of ACP5 protein] and formononetin inhibits the reaction [Streptozocin results in increased expression of ACP5 mRNA] CTD PMID:35315182 furan increases expression EXP 6480464 furan results in increased expression of ACP5 mRNA CTD PMID:25539665 genistein decreases expression EXP 6480464 Genistein results in decreased expression of ACP5 mRNA CTD PMID:12075121 genistein multiple interactions ISO Acp5 (Mus musculus) 6480464 [Zinc Sulfate co-treated with Genistein co-treated with CSF1 protein co-treated with TNFSF11 protein] results in decreased expression of ACP5 mRNA CTD PMID:17295206 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ACP5 mRNA CTD PMID:22061828 guanethidine affects expression EXP 6480464 Guanethidine affects the expression of ACP5 protein CTD PMID:14527964 guanethidine increases expression EXP 6480464 Guanethidine results in increased expression of ACP5 mRNA CTD PMID:14527964 Heptachlor epoxide increases expression ISO Acp5 (Mus musculus) 6480464 Heptachlor Epoxide results in increased expression of ACP5 mRNA CTD PMID:25270620 indometacin decreases expression EXP 6480464 Indomethacin results in decreased expression of ACP5 mRNA CTD PMID:25972201 iron dichloride multiple interactions EXP 6480464 ferrous chloride inhibits the reaction [Dithionite results in decreased activity of ACP5 protein] CTD PMID:6886379 iron dichloride decreases expression ISO ACP5 (Homo sapiens) 6480464 ferrous chloride results in decreased expression of ACP5 mRNA CTD PMID:35984750 ivermectin decreases expression ISO ACP5 (Homo sapiens) 6480464 Ivermectin results in decreased expression of ACP5 protein CTD PMID:32959892 KN-93 multiple interactions ISO Acp5 (Mus musculus) 6480464 KN 93 affects the reaction [[Cadmium co-treated with TNFSF11 protein co-treated with CSF1R protein] affects the expression of ACP5 protein] CTD PMID:32522522 linsidomine increases oxidation EXP 6480464 linsidomine results in increased oxidation of ACP5 protein CTD PMID:28086193 lipopolysaccharide multiple interactions ISO Acp5 (Mus musculus) 6480464 CSF1R affects the reaction [Lipopolysaccharides results in increased expression of ACP5 mRNA] more ... CTD PMID:22067001 and PMID:30048646 lipopolysaccharide increases expression ISO Acp5 (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of ACP5 mRNA and Lipopolysaccharides results in increased expression of ACP5 protein CTD PMID:22067001 and PMID:30048646 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of ACP5 mRNA CTD PMID:22281203 and PMID:28801915 manganese(II) chloride increases methylation EXP 6480464 manganese chloride results in increased methylation of ACP5 gene CTD PMID:28801915 mangiferin multiple interactions ISO Acp5 (Mus musculus) 6480464 mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] CTD PMID:20683903 Maxacalcitol decreases expression ISO ACP5 (Homo sapiens) 6480464 maxacalcitol results in decreased expression of ACP5 and maxacalcitol results in decreased expression of ACP5 protein CTD PMID:11576942 and PMID:8840326 methimazole increases expression EXP 6480464 Methimazole results in increased expression of ACP5 mRNA CTD PMID:30047161 methylglyoxal increases expression EXP 6480464 Pyruvaldehyde results in increased expression of ACP5 mRNA and Pyruvaldehyde results in increased expression of ACP5 protein CTD PMID:31103701 methylglyoxal multiple interactions ISO Acp5 (Mus musculus) 6480464 [TNFSF11 protein co-treated with Pyruvaldehyde] affects the activity of ACP5 protein more ... CTD PMID:30217477 more ... methylglyoxal increases expression ISO Acp5 (Mus musculus) 6480464 Pyruvaldehyde results in increased expression of ACP5 mRNA CTD PMID:31103701 microcystin-LR increases expression EXP 6480464 cyanoginosin LR results in increased expression of ACP5 protein CTD PMID:37467923 modafinil multiple interactions EXP 6480464 Alendronate inhibits the reaction [modafinil results in increased expression of ACP5 mRNA] CTD PMID:29649498 modafinil increases expression EXP 6480464 modafinil results in increased expression of ACP5 mRNA and modafinil results in increased expression of ACP5 protein CTD PMID:29649498 mono(2-ethylhexyl) phthalate multiple interactions ISO Acp5 (Mus musculus) 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ACP5 mRNA CTD PMID:36189433 Morroniside decreases expression ISO Acp5 (Mus musculus) 6480464 morroniside results in decreased expression of ACP5 mRNA CTD PMID:34638983 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of ACP5 mRNA CTD PMID:16026605 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of ACP5 mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ACP5 mRNA CTD PMID:28943392 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of ACP5 mRNA CTD PMID:25380136 naringin multiple interactions ISO Acp5 (Mus musculus) 6480464 naringin inhibits the reaction [[TNFSF11 protein co-treated with CSF1R protein] results in increased expression of ACP5 mRNA] and naringin inhibits the reaction [Polymethyl Methacrylate analog results in increased expression of and results in increased activity of ACP5 protein] CTD PMID:21835177 and PMID:24376342 naringin decreases expression ISO Acp5 (Mus musculus) 6480464 naringin results in decreased expression of ACP5 mRNA CTD PMID:24376342 niclosamide multiple interactions ISO ACP5 (Homo sapiens) 6480464 Niclosamide inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] CTD PMID:26792726 niclosamide multiple interactions ISO Acp5 (Mus musculus) 6480464 Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of ACP5 mRNA] CTD PMID:28824321 nitric acid increases expression EXP 6480464 Nitric Acid results in increased expression of ACP5 protein CTD PMID:16436523 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of ACP5 mRNA CTD PMID:33484710 NMN zwitterion multiple interactions EXP 6480464 Nicotinamide Mononucleotide inhibits the reaction [Aluminum Chloride results in increased expression of ACP5 protein] CTD PMID:30292833 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of ACP5 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of ACP5 mRNA CTD PMID:25729387 ozone multiple interactions ISO Acp5 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ACP5 mRNA CTD PMID:34911549 paracetamol affects expression ISO Acp5 (Mus musculus) 6480464 Acetaminophen affects the expression of ACP5 mRNA CTD PMID:17562736 phenethyl caffeate multiple interactions EXP 6480464 caffeic acid phenethyl ester inhibits the reaction [Dexamethasone results in increased activity of ACP5 protein] CTD PMID:28363435 poly(ethylene) decreases expression ISO ACP5 (Homo sapiens) 6480464 Polyethylene results in decreased expression of ACP5 mRNA CTD PMID:15585240 poly(methyl methacrylate) macromolecule multiple interactions ISO Acp5 (Mus musculus) 6480464 naringin inhibits the reaction [Polymethyl Methacrylate analog results in increased expression of and results in increased activity of ACP5 protein] and Polymethyl Methacrylate analog results in increased expression of and results in increased activity of ACP5 protein CTD PMID:24376342 potassium dichromate decreases activity EXP 6480464 Potassium Dichromate results in decreased activity of ACP5 protein CTD PMID:16866188 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of ACP5 mRNA CTD PMID:30047161 rac-lactic acid decreases expression ISO ACP5 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of ACP5 mRNA CTD PMID:30851411 resveratrol multiple interactions ISO ACP5 (Homo sapiens) 6480464 resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased activity of ACP5 protein] CTD PMID:16267019 rotenone multiple interactions ISO ACP5 (Homo sapiens) 6480464 Rotenone inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] CTD PMID:19900598 rotenone increases expression EXP 6480464 Rotenone results in increased expression of ACP5 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO Acp5 (Mus musculus) 6480464 4-(5-benzo(1 more ... CTD PMID:29127033 SB 431542 multiple interactions ISO ACP5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sclareol decreases expression ISO Acp5 (Mus musculus) 6480464 sclareol results in decreased expression of ACP5 mRNA and sclareol results in decreased expression of ACP5 protein CTD PMID:33423118 sclareol multiple interactions ISO Acp5 (Mus musculus) 6480464 sclareol inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] and sclareol inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein] CTD PMID:33423118 silibinin multiple interactions EXP 6480464 Silybin inhibits the reaction [ferric ammonium citrate results in increased expression of ACP5 protein] CTD PMID:36087815 silicon dioxide increases expression ISO ACP5 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of ACP5 mRNA CTD PMID:23806026 and PMID:25895662 silicon dioxide increases expression ISO Acp5 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of ACP5 mRNA CTD PMID:29341224 sodium arsenite multiple interactions ISO Acp5 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to sodium arsenite] which affects the expression of ACP5 protein CTD PMID:30742845 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of ACP5 mRNA CTD PMID:22561333 sodium fluoride decreases expression ISO Acp5 (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of ACP5 protein CTD PMID:29127033 sodium fluoride multiple interactions ISO Acp5 (Mus musculus) 6480464 4-(5-benzo(1 more ... CTD PMID:29127033 and PMID:32156525 sodium fluoride increases expression ISO Acp5 (Mus musculus) 6480464 Sodium Fluoride results in increased expression of ACP5 mRNA CTD PMID:29127033 and PMID:32156525 Soman increases expression EXP 6480464 Soman results in increased expression of ACP5 mRNA CTD PMID:19281266 stevioside decreases secretion EXP 6480464 stevioside results in decreased secretion of ACP5 protein CTD PMID:21089163 streptozocin increases expression ISO Acp5 (Mus musculus) 6480464 Streptozocin results in increased expression of ACP5 mRNA CTD PMID:35315182 streptozocin increases activity ISO Acp5 (Mus musculus) 6480464 Streptozocin results in increased activity of ACP5 protein CTD PMID:35315182 streptozocin multiple interactions ISO Acp5 (Mus musculus) 6480464 formononetin inhibits the reaction [Streptozocin results in increased activity of ACP5 protein] and formononetin inhibits the reaction [Streptozocin results in increased expression of ACP5 mRNA] CTD PMID:35315182 succimer multiple interactions ISO Acp5 (Mus musculus) 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ACP5 mRNA and [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ACP5 mRNA CTD PMID:21641980 and PMID:26378955 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of ACP5 mRNA CTD PMID:30047161 sulforaphane increases expression ISO Acp5 (Mus musculus) 6480464 sulforaphane results in increased expression of ACP5 mRNA CTD PMID:30529165 tacrolimus hydrate multiple interactions ISO Acp5 (Mus musculus) 6480464 Tacrolimus inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein] CTD PMID:15207740 telmisartan decreases activity EXP 329956421 telmisartan decreases enzyme activity of Trap and Acp5 in serum of rats with periodontal disease RGD testosterone increases expression EXP 6480464 Testosterone results in increased expression of ACP5 mRNA CTD PMID:15917159 tetrachloromethane decreases expression ISO Acp5 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of ACP5 mRNA CTD PMID:31919559 thalidomide multiple interactions ISO ACP5 (Homo sapiens) 6480464 [Thalidomide co-treated with Dexamethasone] results in decreased expression of ACP5 protein CTD PMID:16079895 theophylline increases expression EXP 6480464 Theophylline results in increased expression of ACP5 mRNA and Theophylline results in increased expression of ACP5 protein CTD PMID:26851681 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ACP5 mRNA CTD PMID:23411599 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ACP5 mRNA CTD PMID:28943392 thymol multiple interactions ISO Acp5 (Mus musculus) 6480464 Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 mRNA] more ... CTD PMID:30048646 thymol sulfate(1-) multiple interactions ISO Acp5 (Mus musculus) 6480464 Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 mRNA] more ... CTD PMID:30048646 titanium dioxide decreases expression ISO Acp5 (Mus musculus) 6480464 titanium dioxide results in decreased expression of ACP5 mRNA CTD PMID:23557971 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of ACP5 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of ACP5 mRNA CTD PMID:25729387 tungsten multiple interactions ISO Acp5 (Mus musculus) 6480464 Tungsten promotes the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] CTD PMID:33146397 uranium atom increases expression EXP 6480464 Uranium results in increased expression of ACP5 protein CTD PMID:16436523 uranium atom multiple interactions EXP 6480464 GHRL protein inhibits the reaction [Uranium results in increased secretion of ACP5 protein] CTD PMID:29477364 uranium atom increases secretion EXP 6480464 Uranium results in increased secretion of ACP5 protein CTD PMID:29477364 valproic acid affects expression ISO Acp5 (Mus musculus) 6480464 Valproic Acid affects the expression of ACP5 mRNA CTD PMID:17292431 valproic acid multiple interactions ISO ACP5 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACP5 mRNA CTD PMID:27188386 valproic acid increases expression ISO ACP5 (Homo sapiens) 6480464 Valproic Acid results in increased expression of ACP5 mRNA CTD PMID:23179753 and PMID:26272509 valproic acid decreases expression ISO ACP5 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of ACP5 mRNA CTD PMID:29154799 venlafaxine hydrochloride decreases expression ISO ACP5 (Homo sapiens) 6480464 Venlafaxine Hydrochloride results in decreased expression of ACP5 mRNA CTD PMID:16341940 vitamin D multiple interactions ISO Acp5 (Mus musculus) 6480464 Vitamin D inhibits the reaction [Ethanol results in increased expression of ACP5 mRNA] CTD PMID:22892342 zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of ACP5 mRNA CTD PMID:21893222 zinc atom decreases activity EXP 6480464 Zinc deficiency results in decreased activity of ACP5 protein CTD PMID:21893222 zinc sulfate multiple interactions ISO Acp5 (Mus musculus) 6480464 [Cryptoxanthins co-treated with Zinc Sulfate] results in decreased expression of ACP5 mRNA more ... CTD PMID:17295206 and PMID:18636177 zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of ACP5 mRNA CTD PMID:21893222 zinc(0) decreases activity EXP 6480464 Zinc deficiency results in decreased activity of ACP5 protein CTD PMID:21893222